CAPTRUST Financial Advisors
ATRA icon

CAPTRUST Financial Advisors’s Atara Biotherapeutics ATRA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,323
Closed -$42.6K – 2178
2023
Q4 		$42.6K Buy
3,323
+2,602
+361% +$60.7K ﹤0.01% 2600
2023
Q3 		$26.7K Buy
+721
New +$32.1K ﹤0.01% 2515
2023
Q2 		– Sell
-412
Closed -$29.9K – 2531
2023
Q1 		$29.9K Buy
+412
New +$40K ﹤0.01% 2235
2022
Q3 		– Sell
-8
Closed -$2K – 2215
2022
Q2 		$2K Sell
8
-1
-11% -$163 ﹤0.01% 4425
2022
Q1 		$2K Sell
9
-2
-18% -$637 ﹤0.01% 4456
2021
Q4 		$4K Hold
11
– – ﹤0.01% 4157
2021
Q3 		$5K Buy
11
+1
+10% +$358 ﹤0.01% 3932
2021
Q2 		$4K Sell
10
-1
-9% -$357 ﹤0.01% 3932
2021
Q1 		$4K Buy
+11
New +$4.86K ﹤0.01% 3793

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return